Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: Cultural Differences in Treatment Preferences and Perceptions of Acne
This clinical trial update notes that study NCT03192163, which explored cultural differences in treatment preferences and perceptions among …
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: DUAC® Early Onset Efficacy Study in Japanese Subjects [Phase 4]
Phase 4 trial update on DUAC for acne vulgaris in Japanese subjects has completed with posted results.
-
FDA approval · 2018-01-24FDA Approved: ADAPALENE AND BENZOYL PEROXIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's original abbreviated new drug application for Adapalene and Benzoyl Peroxide, a generic topical combinatio…
-
FDA approval · 2018-01-23FDA Approved: ADAPALENE AND BENZOYL PEROXIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Padagis Israel Pharmaceuticals Ltd's Adapalene and Benzoyl Peroxide combination as an Original Application (ANDA) product f…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Effect of Samples on Acne Treatment With Epiduo® Gel [Phase 4]
Phase 4 trial investigating the effect of samples on acne treatment with Epiduo Gel.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne. [NA]
A completed clinical trial evaluating the effectiveness and tolerance of two acne treatments in subjects with mild to moderate acne (Acne Vu…
-
CLINICAL_TRIALS trial_result · 2018-01-08Clinical Trial Update: U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne [Phase 4]
Phase 4 open-label trial evaluating MAXCLARITY II for acne vulgaris completed with results posted.
-
FDA approval · 2017-12-22FDA Approved: TAZAROTENE — Original Application (Mayne Pharma)
FDA approved Mayne Pharma's original ANDA for tazarotene, enabling the generic topical retinoid product to enter the market.
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris [Phase 2]
Phase 2 trial update on the efficacy and safety of IDP-120 Gel for acne vulgaris has been completed.
-
FDA approval · 2017-12-15FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved an original application for Clindamycin Phosphate and Benzoyl Peroxide, a topical acne treatment manufactured by Sun Pharmaceut…
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial Acne [NA]
This clinical trial update reports the completion of a feasibility study evaluating the Ulthera System for treating moderate-to-severe facia…
-
FDA approval · 2017-09-29FDA Approved: ISOTRETINOIN — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's isotretinoin as a generic version under an Original Application (ANDA 207792) for the treatment…
-
FDA approval · 2017-09-27FDA Approved: DOXYCYCLINE HYCLATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' doxycycline hyclate generic under an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes [Phase 2]
Phase 2 trial evaluating BPX-01 minocycline 1% topical gel for reducing Propionibacterium acnes in acne vulgaris; study completed with resul…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females. [EARLY_Phase 1]
A Phase 1 trial evaluating Next Science acne creams for facial acne in adult females was terminated after six months.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris [Phase 4]
Phase 4 clinical trial comparing a clindamycin + benzoyl peroxide formulation to an azelaic acid formulation for acne vulgaris, with results…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Identifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin Treatment
A completed clinical trial identifying genetic predictors of severe acne vulgaris and evaluating the outcome of oral isotretinoin treatment.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris [Phase 4]
This Phase 4 clinical trial evaluates the effectiveness, safety, and tolerability of Duac Akne Gel and Epiduo Gel in treating facial acne vu…
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: Japanese Phase 1 Study of GSK2585823 [Phase 1]
GlaxoSmithKline's GSK2585823 completed a Japanese Phase 1 trial for acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris [Phase 2]
A Phase 2 clinical trial update assessing the safety and efficacy of topical treatments for moderate-to-severe facial acne vulgaris, with th…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris [Phase 1]
Phase 1 pharmacokinetic study evaluating benzoic acid and hippuric acid after topical GSK2585823 in Japanese adults with acne vulgaris; the …
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers [Phase 1]
Phase 1 trial in healthy volunteers evaluated the photoallergic potential of a combination topical gel containing clindamycin phosphate 1.0%…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers [Phase 1]
Phase 1, single-center, evaluator-blinded, randomized, placebo-controlled trial evaluating the phototoxic potential of a topical clindamycin…
-
FDA approval · 2017-07-11FDA Approved: ADAPALENE — Supplemental Application (CALL INC. (dba Rochester Pharmaceuticals))
FDA approved a supplemental application for adapalene, signaling changes to the existing approval (e.g., labeling or formulation).
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris. [Phase 3]
A Phase 3 trial evaluating generic clindamycin phosphate 1% with benzoyl peroxide 5% topical gel for acne vulgaris has been completed, with …